Introduction
============

Gut microbiota is an essential factor in development of cellular and humoral components of the GALT ([@B39]), while its dysbiosis have been correlated with various diseases ([@B10]). Contribution of gut microbiota dysbiosis to the pathogenesis of multiple sclerosis, a chronic inflammatory disease of the CNS is still elusive. There are recent comparative studies on gut microbiota composition in multiple sclerosis patients and healthy subjects that reveal lower abundance of *Faecalibacterium* ([@B9]), *Clostridia* clusters XIVa, IV, *Bacteroides fragilis* and *Sutterella wadsworthensis* ([@B31]) *Butyricimonas* ([@B20]), and *Parabacteroides*, *Adlercreutzia*, and *Prevotella* genera ([@B11]) in multiple sclerosis patients. On the contrary, it has been shown that gut content of *Methanobrevibacter* and *Akkermansia* ([@B20]), *Pseudomonas*, *Mycoplana*, *Haemophilus*, *Blautia*, and *Dorea* genera ([@B11]) is increased in multiple sclerosis patients. More data on the effect of gut microbiota on the inflammatory CNS pathology has been obtained from studies on EAE, an animal model of multiple sclerosis. These data support the idea that the gut microbiota dysbiosis is actively contributing to development and progression of multiple sclerosis ([@B34]; [@B6]; [@B23]). Moreover, various bacteria and their products have been shown beneficial in EAE, for instance, *B. fragilis* and its capsular polysaccharide A, *Salmonella typhimurium* expressing the CFA/I fimbriae from *E. coli*, *Bifidobacterium animalis*, *Lactobacillus* spp. as well as a probiotic mixture of *Lactobacillus* spp. with *Bifidobacterium bifidum* and *Streptococcus thermophilus* (reviewed in [@B29]). Gut microbiota-imposed regulation of anti-CNS immune response is performed through generation of tolerogenic dendritic cells and regulatory T cells. Both cell types are induced and propagated in response to various food and microbiota products, including retinoic acid and short chain fatty acids (SCFA), such as butyrate and propionate ([@B1]; [@B3]). Regulatory T cells derived in response to gut bacterial products have been shown efficient in restraining CNS autoimmunity ([@B33]). Hence, the adjustment of the deviated gut microbiota could be a valuable strategy for the prevention and treatment of multiple sclerosis.

Interleukin (IL-10) is a prototypic regulatory cytokine that modulates both innate and adaptive immune response and prevents inappropriate and destructive immune activity as observed in autoimmune disorders ([@B26]). Accordingly, IL-10 knockout mice are more susceptible to induction of EAE ([@B7]), while IL-10 was shown efficient in preventing EAE ([@B38]; [@B14]). Importantly, IL-10 is considered as the major immunomodulatory cytokine in the gut microbiota--GALT interaction ([@B25]). It is produced by both gut parenchyma and GALT cells, including epithelial cells, macrophages, T cells, B cells, dendritic cells, NK cells and innate lymphoid cells ([@B25]). Notably, its production by GALT regulatory T cells was shown essential for anti-encephalitogenic activity of these cells in EAE ([@B44]).

AO rats are highly resistant to EAE induction ([@B30]), while DA rats develop EAE even after mild immunization ([@B42]). We have identified various differences between the strains in peripheral lymphoid organs where anti-CNS immune response is initiated and propagated, as well as in the CNS itself where the immune response is perpetuated and developed into full blown inflammatory response. In general, DA rats, unlike AO rats developed strong autoimmune response, characterized by abundance of IFN-γ-producing T helper (Th)1 cells and IL-17-producing Th17 cells. Consequently, intensive CNS inflammation was observed in DA rats, but not in AO rats (reviewed in [@B32]). In our recent work, AO and DA rats have been compared for their GALT cellular composition and proinflammatory cytokine production as well as for their gut microbiota ([@B41]). Differences between the strains within the GALT, including lower percentage of CD4^+^ T cells and reduced generation of IL-17 and IFN-γ in MLN and PP of AO rats were determined ([@B41]). Microbial analyses of non-immunized animals have shown higher diversity of *Lactobacillus* spp. in EAE-resistant AO rats comparing to DA rats. Moreover, an uncultivated species of *Turicibacter* genus was found to be exclusively present in feces of AO rats ([@B41]).

Here, we present data on the gut microbiota composition in AO and DA rats after EAE induction and we identify potential microbes involved in alleviation of EAE symptoms. Also, production of IL-10, as the major immunoregulatory cytokine, by GALT cells is analyzed in comparison to IL-17 and IFN-γ production.

Materials and Methods {#s1}
=====================

Experimental Animals, EAE Induction, and Evaluation
---------------------------------------------------

Female AO and DA rats (8--10 weeks of age) were maintained in the animal facility of the Institute for Biological Research "Sinisa Stankovic". Animal experiments were approved by the local ethics committee (Institute for Biological Research "Sinisa Stankovic", No. 04-04/15). Housing of the rats was performed under conventional conditions. Three to five rats were kept in the same cage. EAE was induced with rat spinal cord homogenate (SCH) in PBS (50% w/v) mixed with equal volume of CFA (Difco, Detroit, MI, USA). The animals were injected subcutaneously into the hock of one hind limb. The rats were monitored daily for c.s. of EAE, and scored according to the following scale: 0, no c.s.; 1, flaccid tail; 2, hind limb paresis; 3, hind limb paralysis; 4, moribund state or death. DA rats had EAE onset on 9--11 d.p.i. (c.s. 1), peak on 12--16 d.p.i. (c.s. 2--4) and recovery on 18--22 d.p.i. (c.s. 1 or less).

DGGE Analysis and DNA Sequencing
--------------------------------

Data on microbiota composition were derived from three independent experiments. In one of these experiments non-immunized and immunized rats were littermates (AO samples 1--12, DA samples 13--24, as presented in **Figure [2](#F2){ref-type="fig"}**), while in the remaining experiments AO and DA rats were of the same age and sex (AO samples 25--30, 39, 40, DA samples 31--38, as presented in **Figure [2](#F2){ref-type="fig"}**). Extraction of bacterial DNA from frozen fecal samples was done using the QIAamp DNA stool minikit (Qiagen, Hilden, Germany). DGGE analysis and gel manipulation after electrophoresis was entirely performed as described previously ([@B28]). Lactobacillus-specific primer Lab-0159f paired with the universal reverse primer Uni-0515-GCr (Metabion International, Martinsried, Germany) were used ([@B19]). Fragments of interest were excised from the gel and macerated, and the suspension was incubated for 10 min at 98°C ([@B28]). After incubation, the suspension was centrifuged to pellet gel particles. The supernatant (30 μl) was used in PCR with Lab-0159f and Uni-0515GCr primers ([@B19]). The obtained PCR products were purified using the QIAquick PCR purification kit (Qiagen) and ligated into the pBluescriptT/A vector ([@B45]). Ligated constructs were transformed in Ca~2~-induced competent DH5α cells ([@B18]), and insert-containing transformants were selected as white colonies on Luria agar (LA) plates containing 100 μg/ml ampicillin and 20 μg/ml X-Gal (5-bromo-4-chloro-3-indolyl-β-[D]{.smallcaps}-galactoside) as recommended by Promega. For each excised DNA band, one white colony was picked and plasmids were isolated using the QIAprep spin miniprep kit (Qiagen). The sequencing of the isolated insert-containing pBluescriptT/A plasmids was done with M13F/R primers at Macrogen Europe Service, Amsterdam, Netherlands ^[1](#fn01){ref-type="fn"}^. Sequence annotation and the database searches for sequence similarities were performed with the BLAST tool available online^[2](#fn02){ref-type="fn"}^.

Phylogenetic Analysis
---------------------

The phylogenetic inferences were obtained by MEGA version 7.0 ([@B22]). Multiple DNA sequence alignments were performed using Clustal W with default parameters. The construction of a DA/AO gut microbiota phylogenetic tree was conducted by the Maximum Likelihood (ML) method based on the Tamura--Nei model. Bootstrapping of 1000 replicates was used to infer confidence levels of ML tree. The analysis involved 30 nucleotide sequences, 16S rRNA genes obtained by DGGE analysis (see above).

Isolation of Cells, Cell Culturing, and Generation of Supernatants
------------------------------------------------------------------

Four MLN were isolated from each rat. MLNC were prepared by mechanical disruption of the lymph nodes. PPs were obtained from the small intestine. PPC were obtained by mechanical disruption. The cells were grown in RPMI-1640 medium supplemented with 5% FCS (PAA Laboratories). MLNC (2.5 × 10^6^/ml) and PPC (2 × 10^6^/ml) were stimulated with concanavalin A (ConA, Sigma-Aldrich, 2.5 μg/ml) for 24 h and subsequently cell culture supernatants were collected and kept frozen until assayed.

ELISA
-----

Cytokine concentration in cell culture supernatants was determined by sandwich ELISA using MaxiSorp plates (Nunc, Rochild, Denmark). For IL-10 detection Rat IL-10 DuoSet ELISA was used according to the manufacturer's instructions (R&D Systems, Minneapolis, MN, USA). For IFN-γ and IL-17 detection anti-cytokine paired antibodies were used according to the manufacturer's instructions (eBioscience, San Diego, CA, USA). The antibodies were as follows: anti-rat IFN-γ purified mouse monoclonal (DB1), anti-rat IFN-γ biotinylated rabbit polyclonal, anti-mouse/rat IL-17A purified rat monoclonal (eBio17CK15A5), and anti-mouse/rat IL-17A biotinylated rat monoclonal (eBio17B7). Samples were analyzed in duplicates and the results were calculated using standard curves made on the basis of known concentrations of the recombinant rat IL-10 (R&D Systems) and IFN-γ and IL-17 (Peprotech, Rocky Hill, NJ, USA).

Statistical Analysis
--------------------

A Student's *t*-test (two-tailed) was performed for statistical analysis. A *p*-value less than 0.05 was considered statistically significant.

Results
=======

Evaluation of *Lactobacillus* spp. Diversity
--------------------------------------------

In order to determine possible microbial players responsible for alleviation of EAE symptoms in DA rats as well as for the EAE-resistance of AO rats, gut microbial diversity was characterized by DGGE analysis of rDNA amplicons using DNA isolated from fecal samples as templates and Lab-0159f and Uni-0515GCr primer set. In total, 30 unique DNA fragment bands (16 from AO and 14 from DA rat fecal samples) have been cloned and sequenced (**Figure [1](#F1){ref-type="fig"}**). The sequence analysis revealed that most of the bands (19/30) belonged to *Lactobacillus* species (99--100% nucleotide sequences identity) (**Table [1](#T1){ref-type="table"}**). Among 19 sequences belonging to *Lactobacillus* sp. the most abundant were *Lactobacillus kalixensis*, *L. johnsonii*, *L. intestinalis*, and *L. faecis* that were detected in all samples, presumably constituting the core measurable microbiota (**Figure [2](#F2){ref-type="fig"}**; **Table [1](#T1){ref-type="table"}**). *L. helveticus*, *L. murinus/animalis*, and *L. vaginalis* as well as *Enterococcus* sp. were sporadically present in AO and DA rats, both healthy and with EAE symptoms.

![**Denaturing gradient gel electrophoresis profiles of rDNA amplicons obtained using a *Lactobacillus*-specific primer set on bacterial DNA isolated from fecal tissue samples of AO and DA rats.** Each lane represents sample of an individual rat. Total of 40 samples (20 from each of the strains) was analyzed. Distribution of samples between the strains and among different time points is presented in **Figure [2](#F2){ref-type="fig"}**. Bands indicated by numbers (1--30) were excised, cloned, and sequenced.](fmicb-07-02005-g001){#F1}

![**The identity of the rDNA clones obtained from DGGE bands related to the rats and the period of EAE induction.** The numbers on the *y*-axis (1--30) correlate with the numbers of the bands excised, cloned, and sequenced, while the numbers on the *x*-axis correspond to the numbers of lanes as presented in **Figure [1](#F1){ref-type="fig"}**. Each lane represents sample of an individual rat. Total of 40 samples (20 from each of the strains) was analyzed. Five samples were collected before the immunization (non-immunized rats -- NI), three samples were collected at 6 d.p.i., and 12 samples were collected at 12--16 d.p.i., from each of the strains. There were four samples of DA rats that had no clinical symptoms of EAE (NS).](fmicb-07-02005-g002){#F2}

###### 

Clones with the percentage of identity to known sequences in BLAST database.

  No. of band   Species^a^                                                                                   NSI (%)
  ------------- -------------------------------------------------------------------------------------------- --------------
  1             Uncultured Firmicutes bacterium clone TM1-142 16S ribosomal RNA gene, partial sequence       98
  2             Uncultured *Lachnospiraceae* bacterium clone MS051A1_A08 16S ribosomal RNA gene              95
                Uncultured Clostridiales bacterium gene for 16S rRNA, partial sequence, clone: M_Fe_Clo047   95
  3             *Enterococcus faecium/faecalis/durans*                                                       93
                *Lactobacillus casei* strain A5                                                              
  4             *Lactobacillus helveticus*                                                                   99
  5             *Lactobacillus helveticus*                                                                   99
  6             Uncultured *Lachnospiraceae* bacterium clone 78 16S ribosomal RNA gene                       99
                Uncultured Firmicutes bacterium clone CM2-40 16S ribosomal RNA gene, partial sequence        99
  7             Uncultured *Lachnospiraceae* bacterium clone MS051A1_A08 16S ribosomal RNA gene              96
                Uncultured Clostridiales bacterium gene for 16S rRNA, partial sequence, clone: M_Fe_Clo047   95
  8             *Turicibacter* sp. LA62                                                                      98
  9             *Lactobacillus intestinalis* TH4                                                             100
  10            *Lactobacillus johnsonii* 17c                                                                99
  11            *Burkholderiales* bacterium clone Cat004D_G05 (Proteobacteria)                               99
                *Undibacterium oligocarboniphilum* strain EM 1                                               
  12            Uncultured Firmicutes bacterium clone CTF1-97                                                100
  13            *Lactobacillus faecis* FZB1                                                                  100
  14            *Lactobacillus intestinalis* TH4                                                             99
  15            *Lactobacillus faecis* FZB1                                                                  100
  16            *Lactobacillus faecis* FZB1                                                                  99
  17            Uncultured Proteobacteria clone TCM2-12                                                      99
                *Anaerobiospirillum* sp. (Proteobacteria)                                                    95
  18            Uncultured Firmicutes bacterium clone TCF2-116                                               92
                Uncultured *Lachnospiraceae* bacterium clone FecI012                                         92 (3% gaps)
  19            *Lactobacillus johnsonii* 17c                                                                99
  20            Uncultured *Lachnospiraceae* bacterium clone MS051A1_A08                                     96
                Uncultured Clostridiales bacterium gene for 16S rRNA                                         95
  21            *Lactobacillus murinus*                                                                      100
                *Lactobacillus animalis* TSU4                                                                100
  22            *Lactobacillus kalixensis* CCUG 48459                                                        100
                *Lactobacillus intestinalis*                                                                 95
  23            *Lactobacillus kalixensis* CCUG 48459                                                        100
  24            *Lactobacillus johnsonii* 17c                                                                99
  25            *Lactobacillus faecis* FZB1                                                                  99
  26            *Lactobacillus intestinalis* TH4                                                             100
  27            *Lactobacillus kalixensis* CCUG 48459                                                        100
  28            *Lactobacillus vaginalis*                                                                    99
  29            *Lactobacillus intestinalis* TH4                                                             99
  30            *Lactobacillus faecis* FZB1                                                                  99

a

Species were named according to their closest relative. NSI, nucleotide sequence identity.

Further, the presence of specific bands in DGGE profiles of AO and DA rats was evaluated using Fisher's exact test, where only the clearly visible bands were counted. Results of Fisher's exact test revealed the presence of *Lachnospiraceae* exclusively in DA rats, regardless of immunization, both in healthy rats and those with EAE symptoms. Similarly, bacteria belonging to *Turicibacter* sp. were detected in DA rats both healthy and with EAE symptoms, but not in non-immunized DA rats. On the other hand, one group of bacteria belonging to *Firmicutes* and bacteria belonging to *Proteobacteria* (*Burkholderiales*, *Undibacterium oligocarboniphilum*) were detected only in DA rats from 12 to 15 d.p.i. in the peak of the disease (**Figure [2](#F2){ref-type="fig"}**; **Table [2](#T2){ref-type="table"}**). In general, in EAE-resistant healthy AO rats only lactobacilli and enterococci were detected, except in the case of two AO rats (non-immunized and 16 d.p.i.) where *Anaerobiospirillum* was detected together with an immunized DA rat (15 d.p.i.).

###### 

The abundance of bands indicated by numbers (1--30) in **Figure [1](#F1){ref-type="fig"}** (given in percentage) in AO and DA rats and in different clinical status.

                                                 AO    DA                            
  ---- ----------------------------------------- ----- ------- ------- ----- ------- -------
  1    *Firmicutes*                              20    0       16,67   40    0       58,33
  2    *Lachnospiraceae* (2)                     0     0       0       40    0       16,67
  3    *Enterococcus* sp. (3)                    20    0       41,67   20    0       41,67
  4    *L. helveticus* (4)                       0     0       0       0     0       16,67
  5    *L. helveticus* (5)                       20    0       0       0     0       0
  6    *Lachnospiraceae* (6)                     0     0       0       0     0       8,33
  7    *Lachnospiraceae* (7)                     0     0       0       20    0       16,67
  8    *Turicibacter* (8)                        0     0       0       0     0       33,33
  9    *L. intestinalis* (*9*)                   0     0       0       0     0       16,67
  10   *L. johnsonii* (*10*)                     0     0       0       0     0       25
  11   *Undibacterium oligocarboniphilum* (11)   0     0       0       0     0       25
  12   *Firmicutes* (12)                         0     0       0       0     0       25
  13   *L. faecis* (*13*)                        0     0       33,33   0     0       8,33
  14   *L. intestinalis* (14)                    0     0       25      0     0       8,33
  15   *L. faecis* (15)                          0     0       33,33   0     0       25
  16   *L. faecis* (16)                          20    0       16,67   0     0       0
  17   *Anaerobiospirillum* (17)                 20    0       8,33    0     0       8,33
  18   *Lachnospiraceae* (18)                    0     0       0       0     0       25
  19   *L. johnsonii* (19)                       0     0       0       0     0       16,67
  20   *Lachnospiraceae* (20)                    0     0       8,33    0     0       8,33
  21   *L. murinus/animalis* (21)                0     66,67   8,33    0     0       0
  22   *L. kalixensis* (*22*)                    20    0       0       60    100     0
  23   *L. kalixensis* (23)                      20    0       8,33    60    100     8,33
  24   *L. johnsonii* (24)                       100   100     100     100   100     100
  25   *L. faecis* (25)                          100   100     100     100   100     100
  26   *L. intestinalis* (26)                    100   100     100     100   100     100
  27   *L. kalixensis* (27)                      60    100     91,67   100   100     100
  28   *L. vaginalis* (28)                       40    33,33   41,67   60    0       8,67
  29   *L. intestinalis* (29)                    20    100     0       80    100     33,33
  30   *L. faecis* (30)                          60    33,33   8,33    60    66,67   0

The band numbers correspond to band numbers given in

Figure

1

.

Finally, ML phylogenetic analysis separated DA/AO gut microbiota into two distinct groups (**Figure [3](#F3){ref-type="fig"}**). Larger group, the Group I includes phylum *Firmicutes* and bacteria from the families *Lactobacillaceae*, *Enterococcaceae*, and *Turicibacteraceae*. Smaller and less conserved group, the Group II consists of bacteria belonging to phylum *Firmicutes* and Proteobacteria including families *Lachnospiraceae*, *Oxalobacteraceae*, and *Succinivibrionaceae*. Interestingly, the results of ML phylogenetic analysis revealed that the clones 2 and 7 (**Figure [1](#F1){ref-type="fig"}**; **Table [1](#T1){ref-type="table"}**) detected only in healthy DA rats belong to the same phylogenetic group within family *Lachnospiraceae*, possibly the same species (**Figure [3](#F3){ref-type="fig"}**). In contrast the clones 6 and 18 that were only detected in DA rats with EAE symptoms according to ML phylogeny analysis possibly belonging to different species of the family *Lachnospiraceae*.

![**Phylogenetic inferences of 16S rRNA gene among bacteria isolated from DA and AO feces samples.** A phylogenetic tree of 16S rRNA genes was constructed with the maximum likelihood (ML) method using a Tamura--Nei model distance matrix. The confidence levels were calculated from 1000 bootstrap resamples of alignment used for phylogenetic inferences by ML method. Black circles represent the nodes with a support bootstrap value of ≥40%. Numbers in brackets represent the number of corresponding excised, cloned, and sequenced DGGE band. Group I, including phylum *Firmicutes* and bacteria from the families *Lactobacillaceae*, *Enterococcaceae*, and *Turicibacteraceae* is denoted by full semicircular line. Group II consisting of bacteria belonging to phylum *Firmicutes* and *Proteobacteria* including families *Lachnospiraceae*, *Oxalobacteraceae*, and *Succinivibrionaceae* is denoted by dashed semicircular line.](fmicb-07-02005-g003){#F3}

IL-10 Production in MLNC of AO and DA Rats
------------------------------------------

IL-10 production was determined in cultures of MLNC obtained from non-immunized AO and DA rats (day 0) and at day 6 and days 13--16 after the immunization. IL-10 release was similar in untreated AO rats on day 0 and day 6, but then decreased on days 13--16 (**Figure [4A](#F4){ref-type="fig"}**). On the contrary, spontaneous IL-10 generation increased on day 6 in DA rats and then returned to basal levels on days 13--15 (**Figure [4A](#F4){ref-type="fig"}**). ConA stimulated IL-10 generation in MLNC of both strains in all groups of samples and consequently similar strain-specific pattern of IL-10 production was observed in ConA-stimulated MLNC as in unstimulated cultures. Interestingly, IL-10 production was significantly higher in DA rat than in AO rat samples in all of the analyzed samples, except for non-stimulated cultures of day 0. IFN-γ and IL-17 production were analyzed in parallel. The same pattern of IFN-γ and IL-17 production was observed as in our previous study ([@B41]). In order to get insight into IL-10 production relative to production of these major pro-inflammatory cytokines, ratios of IL-10 to IFN-γ and IL-17 were calculated for each sample. The only significant difference between the strains was observed with day 6 samples, where both IL-10/IFN-γ and IL-10/IL-17 ratios were higher in DA rats than in AO rats (**Figures [4B,C](#F4){ref-type="fig"}**). Thus, it is clear that EAE-resistant and EAE-prone rats have different regulation of IL-10 production in MLN both in non-immunized and EAE rats.

![**IL-10 production in MLNC.** MLNC were isolated from non-immunized (0 d.p.i.) AO and DA rats or from immunized rats at 6 d.p.i and 13--15 d.p.i. Cytokine levels were measured in supernatants of 24 h cultures of un-stimulated (0) or ConA-stimulated (ConA) cells. IL-10 levels are presented as mean ± SD from at least six rats per group **(A)**. Ratios of IL-10 levels to IFN-γ **(B)** or to IL-17 **(C)** levels determined in ConA-stimulated cultures are presented as individual values (white squares) and as mean (black squares with line). ^∗^*p* \< 0.05 AO vs. DA; "*p* \< 0.05 to 0 d.p.i. of the same strain; ^\#^*p* \< 0.05 0 vs. ConA.](fmicb-07-02005-g004){#F4}

IL-10 Production in PPC of AO and DA Rats
-----------------------------------------

IL-10 production was determined in cultures of PPC obtained from non-immunized AO and DA rats (day 0) and at day 6 and days 13--16 after the immunization. Spontaneous and ConA-stimulated IL-10 release was higher in non-immunized rats of both strains than on day 6 or days 13--16 (**Figure [5A](#F5){ref-type="fig"}**). The only exemption was ConA stimulated IL-10 generation in PPC of DA rats on days 13--16 which was similar to the level observed in samples of non-immunized counterparts. Generally, ConA was inefficient in inducing IL-10 production in PPC of both strains, with an exemption with DA samples obtained on days 13--16. Strain differences were observed only on days 13--15 for both spontaneous and ConA-induced production of the cytokine (**Figure [5A](#F5){ref-type="fig"}**). As for the ratios of IL-10 to IFN-γ and IL-17, the only significant difference between the strains was observed with samples obtained from non-immunized rats, where both IL-10/IFN-γ and IL-10/IL-17 ratios were higher in AO rats (**Figures [5B,C](#F5){ref-type="fig"}**). Thus, these results imply that EAE-resistant and EAE-prone rats have different regulation of IL-10 production in PPC.

![**IL-10 production in PPC.** PPC were isolated from non-immunized (0 d.p.i.) AO and DA rats or from immunized rats at 6 d.p.i and 13--15 d.p.i. Cytokine levels were measured in supernatants of 24 h cultures of un-stimulated (0) or ConA-stimulated (ConA) cells. IL-10 levels are presented as mean ± SD from at least six rats per group **(A)**. Ratios of IL-10 levels to IFN-γ **(B)** or to IL-17 **(C)** levels determined in ConA-stimulated cultures are presented as individual values (white squares) and as mean (black squares with line). ^∗^*p* \< 0.05 AO vs. DA; "*p* \< 0.05 to 0 d.p.i. of the same strain; ^\#^*p* \< 0.05 0 vs. ConA.](fmicb-07-02005-g005){#F5}

Discussion
==========

Gut microbiota composition is different in multiple sclerosis patients and healthy controls ([@B9]; [@B31]; [@B11]; [@B20]). Accordingly, EAE-prone and EAE-resistant rats are shown to differ for gut microbiota composition in our study. Specifically, *Turicibacter* sp. and the members of *Lachnospiraceae* family are identified as possible EAE resistance/recovery promoters. Also, production of IL-10 as the major gut immunoregulatory cytokine is diverse between the rat strains. Our results imply that microbiota--GALT interaction differs in the rat strains and that this dissimilarity could be important for their susceptibility/resistance to the CNS autoimmunity.

It could be referred that gut microbiota composition of AO rats is more stable, representing core measurable microbiota, while the results obtained for DA rats point to higher diversity of bacterial groups, especially at the peak of the diseases. However, the higher diversity of bacteria in DA rats could be result of lower number of lactobacilli as dominant groups in DA rats. Thus, other microbial groups overgrow due to the lack of lactobacilli. According to [@B4], *Turicibacter* sp. constitutes the core measurable microbiota in mice and it was suggested that its quantitative variations were related to the host genotype. The increased *Turicibacter* gut content was correlated with increase in butyric acid, a short chain fatty acid (SCFA) with immunomodulatory potential ([@B47]). In addition, possible anti-inflammatory effects of *Turicibacter* were suggested ([@B36]; [@B46]; [@B43]). In our previous study, when non-immunized AO and DA rats were compared, *Turicibacter* was detected only in feces of AO rats ([@B41]). In contrast to previous results, in this study *Turicibacter* sp. was not detected in AO, but only in DA rats, in samples obtained at the time of EAE peak when higher production of IL-10 by MLNC and PPC was also observed. The discrepancy of the obtained results could be explained by the inter-individual microbial diversity ([@B16]), as well as by limitations of molecular method used in the study which allows detection of small percent (1%) of dominant microbial groups present in samples at the time of sampling. It has been established that only part of the microbial community members are stabile over time and participate in individual core microbial population, pointing to the conclusion that *Turicibacter* possibly does not belong to the core microbiota in the rats used in our studies. On the other hands, a number of environmental and host factors that are still not well known could cause the observed changes. Nevertheless, the obtained results could be a good indication for future studies. As our data do not allow adequate statistical analysis on the correlation between IL-10 generation and the presence of *Turicibacter* sp. in the gut microbiota, it is on the future studies to determine if there is mutual stimulatory effect between IL-10 and *Turicibacter* sp. Also, future studies should determine if some other host factors stimulate the presence of Turicibacter sp. in DA rats at the peak of the disease.

In addition, the results of this study revealed that members of the family *Lachnospiraceae* could be linked to the EAE alleviation. It was reported previously that bacteria belonging to the family *Lachnospiraceae* were dominantly present in the gut microbiota in *Clostridium difficile*-infected animals with mild disease ([@B37]). The authors hypothesized that members of the *Lachnospiraceae* family enabled partially restored colonization resistance against *Clostridium difficile* in the murine gut. Further, decreased prevalence of *Lachnospiraceae* in gut microbiota of patients with inflammatory bowel disease (IBD) was reported ([@B15]). *Lachnospiraceae* are Gram-positive obligate anaerobes that are mostly non-spore forming ([@B13]). Interestingly, the clones 2, 7, and 20, identified as members of *Lachnospiraceae* family, showed higher similarity to *Clostridiales*. Taxon *Clostridiales* is a bacterial order of the phylum *Firmicutes* with important roles in the colonic fermentation of dietary fiber ([@B12]). Moreover, bacteria belonging to order *Clostridiales*, especially members of family *Lachnospiraceae*, were identified as the most active microbial components in the gut of healthy adults and strongly contribute to production of beneficial SCFAs in the gut ([@B12]; [@B35]; [@B24]). Hence, it could be hypothesized that the increase in *Clostridiales* and *Lachnospiraceae* in healthy DA rats is linked to increased production of intestinal butyrate associated with better healthy status.

Generally, large number of factors influence the establishment and maintenance of microbiota composition, including host genetic background, environment, immune response, as well as microbe--microbe interactions ([@B40]). AO and DA rats have different major histocompatibility complex (MHC) haplotype, RT1u and RT1av1, respectively. Since rats of both strains are kept under identical environmental conditions in our studies, it is likely that MHC disparity contributes to established difference in AO and DA gut microbiota. Further, it has recently been shown that fecal micro RNA (miRNA) facilitates host control of the gut microbiota through miRNA-mediated inter-species gene regulation ([@B27]). Hence the possible involvement of miRNA in control of the microbiota composition in AO and DA rats upon EAE induction will be the subject of our further studies.

The observed variation in gut microbiota composition could largely contribute to differential regulatory GALT status in AO and DA rats. Different microbes and their products could potentiate or restrict generation of tolerogenic dendritic cells and regulatory T cells in the GALT. These cells can regulate encephalitogenic immune response locally, as it has been shown that encephalitogenic T cells tend to migrate into the GALT ([@B5]). Also, regulatory T cells can migrate into the CNS where they restrict encephalitogenic T cell proliferation, cytokine production and other effector functions ([@B21]). Importantly, IL-10-producing regulatory T cells have been identified as the primary anti-encephalitogenic population in mice treated with *B. fragilis* capsular polysaccharide A ([@B44]). IL-10 is one of the major regulatory cytokines of the immune system and it has a profound role in microbiota-imposed immunoregulation within the GALT ([@B25]). Although macrophages and B cells are considered as the most potent producers of IL-10 within GALT, it seems that IL-10 produced by regulatory T cells has a dominant role in building a regulatory milieu in the gut tissue (reviewed in [@B17]). Indeed, it was shown that the native human gut microorganisms, mainly clusters IV and XIVa of the genus *Clostridium* stimulate accumulation of IL-10-producing regulatory T cells in the gut ([@B2]). Importantly, *Clostridia* clusters IV and XIVa were found depleted in multiple sclerosis patients ([@B31]). Noteworthy, our previous study showed that proportion of FoxP3^+^ regulatory T cells increased within MLNC and PPC of rats at 13--15 d.p.i. ([@B41]). This increase might, at least partly, contribute to augmented production of IL-10 in DA rat GALT at the peak of EAE.

Higher production of IL-10 was observed in draining lymph nodes of DA rats in comparison to AO rats at day 6 after the immunization in our previous study ([@B8]). Similar results were obtained with MLN in this study: IL-10 release was higher in DA rats before the immunization, as well as at day 6 and days 13--16 after the immunization. Actually, generation of IL-10 in AO rats remained at the basal levels after the immunization, while it increased in DA rats at day 6 and then declined on days 13--16. Interestingly, IL-10 production decreased after the immunization in DA rat PPC and then increased toward basal levels on days 13--16. This implies that redistribution of IL-10-generating cells between PP and MLN or even draining lymph nodes might occur in DA rats after EAE induction. Indeed, our previous results showed that there were changes in cellular composition of MLN and PP from non-immunized toward EAE rats ([@B41]). Specifically, proportion of CD4^+^ T cells among MLN and PP decreased upon immunization in both strains. Also, percentage of CD4^+^ T cells among MLN and PP was higher in DA than in AO rats. These changes might contribute to differential production of IFN-γ, IL-17, and IL-10 observed in our studies. Also, as absolute number of cells per MLN and PP did not differ between non-immunized and immunized rats ([@B41]) the changes in cellular composition imply selective migration of certain cell types to/from MLN and PP. Alternatively, some IL-10-promoting factors could work within MLN and some IL-10 inhibitory elements within PP of immunized DA rats. These two mechanisms are not mutually exclusive and could act in cooperation to modulate IL-10 release in GALT. Further, ratio of IL-10 to proinflammatory cytokine production is higher in AO rats than in DA rats in PPC before the immunization. This implies that basal milieu in PPC of EAE-resistant rats is more immunoregulatory than in EAE-prone rats. The same trend is observed in MLN, yet without statistical difference. However, the ratio is higher in DA rats MLN at day 6 after the immunization thus implying that intensive immunoregulatory activity is present within MLN of EAE-prone rats in the inductive phase of the disease. Detailed studies on the functional significance and mechanisms of the observed modulation of IL-10 production during the course of EAE are warranted.

Conclusion
==========

In this study we have analyzed the gut microbiota composition in AO and DA rats after EAE induction. As a result, *Turicibacter* sp. and the members of *Lachnospiraceae* family were identified as possible EAE-modulating bacteria, while strain specificities between AO and DA rats in GALT IL-10 generation were observed. Our results contribute to a view that functional studies aiming at altering gut microbiota and gut-associated immune response as the primary tool to reduce encephalitogenic immune response in multiple sclerosis are needed.
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AO

:   Albino Oxford

c.s.

:   clinical score

CFA

:   complete Freund's adjuvant

CNS

:   central nervous system

d.p.i.

:   days post immunization

DA

:   Dark Agouti

DGGE

:   denaturing gradient gel electrophoresis

EAE

:   experimental autoimmune encephalomyelitis

FCS

:   fetal calf serum

GALT

:   gut associated lymphoid tissue

IFN

:   interferon

IL

:   interleukin

MBP

:   myelin basic protein

MLN

:   mesenteric lymph node

MLNC

:   MLN cells

NSI

:   nucleotide sequence identity

PBS

:   phosphate buffer saline

PCR

:   polymerase chain reaction

PP

:   Peyer's patch

PPC

:   PP cells

SD

:   standard deviation

Th

:   helper T cells.
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